The Potential Effect of Statins on Rituximab Immunotherapy

Overview

Journal PLoS Med

Specialty General Medicine

Date 2008 Mar 28

PMID 18366253

Citations 2

Authors

Mark S Cragg

Affiliations

Soon will be listed here.

Citing Articles

The Role of Cholesterol in Chronic Lymphocytic Leukemia Development and Pathogenesis.

White A, Best O, Hotinski A, Kuss B, Thurgood L Metabolites. 2023; 13(7).

PMID: 37512506 PMC: 10385576. DOI: 10.3390/metabo13070799.

Altered expression of two zinc transporters, SLC30A5 and SLC30A6, underlies a mammary gland disorder of reduced zinc secretion into milk.

Kumar L, Michalczyk A, McKay J, Ford D, Kambe T, Hudek L Genes Nutr. 2015; 10(5):487.

PMID: 26319140 PMC: 4552687. DOI: 10.1007/s12263-015-0487-x.

References

Maloney D . Rituximab for follicular lymphoma. Curr Hematol Rep. 2003; 2(1):13-22. View

Shan D, Ledbetter J, Press O . Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood. 1998; 91(5):1644-52. View

Polyak M, Ayer L, Szczepek A, Deans J . A cholesterol-dependent CD20 epitope detected by the FMC7 antibody. Leukemia. 2003; 17(7):1384-9. DOI: 10.1038/sj.leu.2402978. View

Maloney D, Smith B, Rose A . Rituximab: Mechanism of action and resistance. Semin Oncol. 2017; 29(1S2):2-9. DOI: 10.1053/sonc.2002.30156. View

Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R . CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346(4):235-42. DOI: 10.1056/NEJMoa011795. View

Hiddemann W, Buske C, Dreyling M, Weigert O, Lenz G, Forstpointner R . Treatment strategies in follicular lymphomas: current status and future perspectives. J Clin Oncol. 2005; 23(26):6394-9. DOI: 10.1200/JCO.2005.07.019. View

Cragg M, Walshe C, Ivanov A, Glennie M . The biology of CD20 and its potential as a target for mAb therapy. Curr Dir Autoimmun. 2004; 8:140-74. DOI: 10.1159/000082102. View

Di Gaetano N, Cittera E, Nota R, Vecchi A, Grieco V, Scanziani E . Complement activation determines the therapeutic activity of rituximab in vivo. J Immunol. 2003; 171(3):1581-7. DOI: 10.4049/jimmunol.171.3.1581. View

Endo A . The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res. 1992; 33(11):1569-82. View

10.

Cragg M, Morgan S, Chan H, Morgan B, Filatov A, Johnson P . Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts. Blood. 2002; 101(3):1045-52. DOI: 10.1182/blood-2002-06-1761. View

11.

Zhuang L, Kim J, Adam R, Solomon K, Freeman M . Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest. 2005; 115(4):959-68. PMC: 1064980. DOI: 10.1172/JCI19935. View

12.

Xia Z, Tan M, Wong W, Dimitroulakos J, Minden M, Penn L . Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia. 2001; 15(9):1398-407. DOI: 10.1038/sj.leu.2402196. View

13.

van de Donk N, Schotte D, Kamphuis M, van Marion A, van Kessel B, Bloem A . Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells. Clin Cancer Res. 2003; 9(15):5735-48. View

14.

Byrd J, Kitada S, Flinn I, Aron J, Pearson M, Lucas D . The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood. 2002; 99(3):1038-43. DOI: 10.1182/blood.v99.3.1038. View

15.

Gallon L, Chhabra D . Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient. Am J Transplant. 2007; 6(12):3017-21. DOI: 10.1111/j.1600-6143.2006.01544.x. View

16.

Clynes R, Towers T, Presta L, Ravetch J . Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med. 2000; 6(4):443-6. DOI: 10.1038/74704. View

17.

Pham L, Tamayo A, Yoshimura L, Lo P, Terry N, Reid P . A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas. Immunity. 2002; 16(1):37-50. DOI: 10.1016/s1074-7613(01)00258-8. View

18.

Katano H, Pesnicak L, Cohen J . Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas. Proc Natl Acad Sci U S A. 2004; 101(14):4960-5. PMC: 387356. DOI: 10.1073/pnas.0305149101. View

19.

Tauzin S, Ding H, Khatib K, Ahmad I, Burdevet D, van Echten-Deckert G . Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts. Blood. 2007; 111(4):2310-20. DOI: 10.1182/blood-2007-05-090985. View

20.

Winiarska M, Bil J, Wilczek E, Wilczynski G, Lekka M, Engelberts P . Statins impair antitumor effects of rituximab by inducing conformational changes of CD20. PLoS Med. 2008; 5(3):e64. PMC: 2270297. DOI: 10.1371/journal.pmed.0050064. View